Assessment of treatment response to immunotherapy in melanoma patients with pathogenic mutations of NRAS, BRAF, CDKN2A and P53.
Year: 2017
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Thomas DeLeon, Benjamin Kipp, Blake Langlais, Thomas Flotte, Jennifer Winters, Heidi E. Kosiorek, Richard Wayne Joseph, Svetomir Markovic, Roxana Stefania Dronca, Matthew Stephen Block, Robert R. McWilliams, Lisa A. Kottschade, Mitesh J. Borad, Kandelaria M. Rumilla, Jesse S Voss, Alan H. Bryce
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2891348737
